fb-pixel tracker
News

Caris Life Sciences Showcases Data on KRAS Mutations in Patients With Non-Small Cell Lung and Pancreatic Cancer at ASCO20 Virtual Scientific Program

The combination of DNA sequencing and whole transcriptome sequencing provides critical insights that can guide treatment decisions across a range of cancers   IRVING, Texas, May 29, 2020 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, will present results from a study today that characterize … Continued

Caris Life Sciences to Present Data Spotlighting Clinical Impact of Precision Medicine in ASCO20 Virtual Scientific Program

Data from 14 studies to highlight role of company’s portfolio of precision medicine technologies in guiding treatment decisions for patients with cancer across tumor types   IRVING, Texas, May 11, 2020 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that the company will … Continued

Caris Life Sciences Launches Whole Exome Sequencing with MI Exome

The most comprehensive suite of molecular testing in the industry includes a new whole exome sequencing (DNA) assay complementing the Company’s breakthrough whole transcriptome sequencing (RNA) performed on every patient    IRVING, Texas, April 22, 2020 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today … Continued

Caris Life Sciences Launches MI FOLFOXai, Improving Overall Survival by 50% for Metastatic Colorectal Cancer Patients

First AI-powered FOLFOX predictor to guide first-line metastatic colorectal cancer treatment   IRVING, Texas, March 31, 2020 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced the launch of MI FOLFOXai, the newest addition to the company’s suite of comprehensive molecular science offerings. MI … Continued

Study Shows That Caris Life Sciences’ ADAPT Biotargeting System™ Has Discovered Protein Expression Pattern Differences Between Two Prostate Cancer Patient Subpopulations

First time findings published in Nucleic Acids Research demonstrate the ability to differentiate exosomes from cancer cell subtypes from the same tumor type offering broad potential applications in biomarker discovery   IRVING, Texas, Feb. 12, 2020 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today … Continued

Caris Life Sciences Appoints New Executive Medical Director

IRVING, Texas, Feb. 11, 2020 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today Matthew Oberley, M.D., Ph.D., has been appointed Executive Medical Director.   Dr. Oberley joined Caris in August 2019 as Senior Medical Director and has functioned as a leading face for … Continued

1 2 3 22

About Our News

Search to find the latest new about Caris Molecular Intelligence®, sign up for news alerts, and be sure to follow us on social media.